UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000058359 |
|---|---|
| Receipt number | R000066716 |
| Scientific Title | Multicenter prospective observational study of untreated metastatic renal cell carcinoma |
| Date of disclosure of the study information | 2025/07/03 |
| Last modified on | 2025/07/03 15:03:43 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Multicenter prospective observational study of untreated metastatic renal cell carcinoma
Acronym
Multicenter prospective observational study of untreated metastatic renal cell carcinoma
Scientific Title
Multicenter prospective observational study of untreated metastatic renal cell carcinoma
Scientific Title:Acronym
Multicenter prospective observational study of untreated metastatic renal cell carcinoma
Region
| Japan |
Condition
Condition
untreated metastatic renal cell carcinoma
Classification by specialty
| Urology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the clinical outcomes of metastatic renal cell carcinoma
Basic objectives2
Others
Basic objectives -Others
To evaluate the clinical outcomes of metastatic renal cell carcinoma
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Pattern of treatment and outcomes of metastatic renal cell carcinoma
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Untreated metastatic renal cell carcinoma
Key exclusion criteria
Patients for whom it is impossible to obtain consent
Target sample size
400
Research contact person
Name of lead principal investigator
| 1st name | Yasuhisa |
| Middle name | |
| Last name | Fujii |
Organization
Institute of Science Tokyo
Division name
Urology
Zip code
113-8519
Address
1-5-45 Yushima, Bunkyo-ku, Tokyo
TEL
03-5803-5295
ikyouro@tmd.ac.jp
Public contact
Name of contact person
| 1st name | Masaharu |
| Middle name | |
| Last name | Inoue |
Organization
Cancer Institute Hospital, Japanese Foundation for Cancer.
Division name
Genitourinary Oncology
Zip code
135-8550
Address
3-8-31 Ariake, Koto-ku, Tokyo
TEL
03-3520-0111
Homepage URL
ikyouro@tmd.ac.jp
Sponsor or person
Institute
Institute of Science Tokyo
Institute
Department
Personal name
Funding Source
Organization
Institute of Science Tokyo
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Institute of Science Tokyo
Address
1-5-45 Yushima, Bunkyo-ku, Tokyo
Tel
03-5803-5295
ikyouro@tmd.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
東京科学大学病院（東京都）、がん研有明病院（東京都）、埼玉県立がんセンター（埼玉県）、獨協医科大学 埼玉医療センター（埼玉県）、がん・感染症センター都立駒込病院（東京都）、土浦協同病院（茨城県）、JAとりで総合医療センター（茨城県）、さいたま赤十字病院（埼玉県）、国立国際医療研究センター国府台病院（千葉県）、大森赤十字病院（東京都）、多摩南部地域病院（東京都）、公立昭和病院（東京都）、草加市立病院（埼玉県）
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 07 | Month | 03 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2022 | Year | 09 | Month | 26 | Day |
Date of IRB
| 2022 | Year | 10 | Month | 11 | Day |
Anticipated trial start date
| 2022 | Year | 10 | Month | 11 | Day |
Last follow-up date
| 2029 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Prospective registration of clinical and pathological information obtained from medical records
Management information
Registered date
| 2025 | Year | 07 | Month | 03 | Day |
Last modified on
| 2025 | Year | 07 | Month | 03 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066716
